For example, EVs carrying siRNAs have been employed in gene therapy for HER2‐positive breast cancer, and EVs showcasing a fragment of IL‐3 have exhibited encouraging outcomes in chronic myeloid leukaemia (CML) patients (Bellavia et al., 2017). Here, ERBB2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.